Evommune (EVMN) Interest Coverage Ratio (2024 - 2026)
Evommune (EVMN) reported Interest Coverage Ratio of 5988.5 for Q1 2026, down 417.9% year-over-year from 1883.78 in Q1 2025, and down 304.39% quarter-over-quarter from 1480.89 in Q3 2025.
Evommune (EVMN) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Interest Coverage Ratio data on file, last reported at 5988.5 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 5988.5, down 417.9% year-over-year; the trailing twelve-month figure through Mar 2026 was 3155.0 (changed N/A YoY), and the FY2025 annual result was 1621.42, up 14.31% from the prior year.
- Interest Coverage Ratio declined to 5988.5 in Q1 2026 per EVMN's latest filing, from 1480.89 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 21454.0 in Q4 2024 and troughed at 5988.5 in Q1 2026.
- A 3-year average of 2371.34 and a median of 1156.31 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio tumbled 52.42% in 2025, then tumbled 417.9% in 2026.
- A 3-year view of Interest Coverage Ratio shows it stood at 21454.0 in 2024, then plunged by 106.9% to 1480.89 in 2025, then plunged by 304.39% to 5988.5 in 2026.
- Business Quant data shows EVMN's Interest Coverage Ratio at 5988.5 in Q1 2026, 1480.89 in Q3 2025, and 1156.31 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | -5,988.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,988.50 |
| Sep 30, 2025 | -1,480.89 |
| Mar 31, 2025 | -1,156.31 |
| Dec 31, 2024 | 21,454.00 |
| Sep 30, 2024 | -971.59 |